Trial of High Dose Lenalidomide in Patients With MDS and AML With Trilineage Dysplasia
Clinical trial NCT00867308 · TERMINATED
Trial details
- NCT number
- NCT00867308
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2009-07-01
- Primary completion
- 2014-05-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.